However, the specific CD26 inhibitor Vildagliptin in combination with Nilotinib did not reveal any significant cooperative effect on engraftment of CML cells in NSG mice [158]. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.